1. S., Baas A. S., Maynard H. D. (2011). FDA-approved poly(ethylene glycol)-protein conjugate drugs.;Polymer Chemistry
2. P., Lin E. Y., Lin K., Pellegrini M., Petter R. C., Chen L. L., Pepinsky R. B. (2006). N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.;Bioconjugation Chemistry
3. P., Pepinsky R. B., Brickelmaier M., Gronke R. S., Hu X., Olivier K., Davar G. (2010). PEGylated interferon beta-1a: Meeting an unmet medical need in the treatment of relapsing multiple sclerosis.;Journal of Interferon and Cytokine Research
4. Betaseron (interferon beta-1b) prescribing information.;Montville,2010
5. Avonex (interferon beta-1a) prescribing information.;Cambridge,2008